Neoanalytics Laboratory INC

Neoanalytics Laboratory INC was paid $3.17M by Medicaid between Jun 2020 and Oct 2024, across 13 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 66% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#129 of 561

Median peer was paid$222K

This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	4,846	$191K
2021	29,870	$839K
2022	47,231	$1.70M
2023	10,076	$395K
2024incomplete	2,305	$47K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	66%	34,595	15,830	$2.09M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	11%	22,231	9,923	$343K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	9.4%	16,290	6,910	$300K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	8.6%	16,315	8,537	$273K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	5.0%	4,597	2,008	$159K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	37	36	$7K
86769		<1%	46	45	$1K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	12	12	$600.00
80053	Comprehensive metabolic panel	<1%	54	53	$45.86
80061	Lipid panel	<1%	38	38	$45.80
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	60	59	$33.54
84443	Thyroid stimulating hormone (TSH)	<1%	38	38	$29.22

1 more codes

36415

Collection of venous blood by venipuncture

0%

15

$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGOH, RONA (CHIEF EXECUTIVE OFFICER)